Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

RACE - Rapid Amplification of cDNA Ends02:35

RACE - Rapid Amplification of cDNA Ends

7.2K
Rapid Amplification of cDNA Ends, or RACE, is one of the most effective methods to obtain a full-length cDNA from an mRNA sequence between a known internal region to the unknown sequence at the 5’ or 3’ end. The unknown region is cloned in the cDNA by a gene-specific primer that binds the known end, and a hybrid primer that attaches a predefined anchor sequence to the unknown end of the cDNA. The sequence in between is amplified by PCR with an anchor primer and a gene-specific...
7.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Compressive stress inhibits proliferation in AsPC-1 pancreatic cancer cells and reduction of Myc protein.

PloS one·2026
Same author

Efficacy of Adjuvant Interferon-β Versus Observation for Resected Nail Apparatus Melanoma: A Multicenter Retrospective Study.

The Journal of dermatology·2026
Same author

Earlier Comprehensive Cancer Genomic Profiling in Gynecologic Cancers May Facilitate Genotype-Matched Therapy: A Prospective Single-Institution Study.

Obstetrics and gynecology international·2026
Same author

C/EBPγ induces epithelial-mesenchymal transition and facilitates DNA double-strand break repair in lung adenocarcinoma cells.

Cell death discovery·2026
Same author

An Exploratory Study to Identify Factors Associated with Recurrence of Generalized Pustular Psoriasis Flares in Adult Patients in Japan.

Acta dermato-venereologica·2026
Same author

Complications and Laboratory Test Findings Among Patients With Generalized Pustular Psoriasis: A Retrospective Chart Review Study.

Experimental dermatology·2026

Related Experiment Video

Updated: Jan 16, 2026

Oncogenic Gene Fusion Detection Using Anchored Multiplex Polymerase Chain Reaction Followed by Next Generation Sequencing
09:49

Oncogenic Gene Fusion Detection Using Anchored Multiplex Polymerase Chain Reaction Followed by Next Generation Sequencing

Published on: July 5, 2019

10.0K

Fusion Gene Detection in Driver Mutation-Negative Melanomas Using RNA-Based Anchored Multiplex Polymerase Chain

Tokimasa Hida1, Masashi Idogawa2, Sayuri Sato1

  • 1Department of Dermatology, Sapporo Medical University School of Medicine, Sapporo, Japan.

Pigment Cell & Melanoma Research
|October 1, 2025
PubMed
Summary

Fusion genes were identified in Japanese melanomas lacking common mutations, offering new therapeutic targets. This RNA-based approach detects actionable gene fusions in driver-negative melanoma.

Keywords:
CIC proteinRNAgene fusionmelanomaproto‐oncogene proteins B‐raf

More Related Videos

Detection and Monitoring of Tumor Associated Circulating DNA in Patient Biofluids
06:53

Detection and Monitoring of Tumor Associated Circulating DNA in Patient Biofluids

Published on: June 8, 2019

9.1K
Visualizing Genetic Variants, Short Targets, and Point Mutations in the Morphological Tissue Context with an RNA In Situ Hybridization Assay
10:57

Visualizing Genetic Variants, Short Targets, and Point Mutations in the Morphological Tissue Context with an RNA In Situ Hybridization Assay

Published on: August 14, 2018

11.2K

Related Experiment Videos

Last Updated: Jan 16, 2026

Oncogenic Gene Fusion Detection Using Anchored Multiplex Polymerase Chain Reaction Followed by Next Generation Sequencing
09:49

Oncogenic Gene Fusion Detection Using Anchored Multiplex Polymerase Chain Reaction Followed by Next Generation Sequencing

Published on: July 5, 2019

10.0K
Detection and Monitoring of Tumor Associated Circulating DNA in Patient Biofluids
06:53

Detection and Monitoring of Tumor Associated Circulating DNA in Patient Biofluids

Published on: June 8, 2019

9.1K
Visualizing Genetic Variants, Short Targets, and Point Mutations in the Morphological Tissue Context with an RNA In Situ Hybridization Assay
10:57

Visualizing Genetic Variants, Short Targets, and Point Mutations in the Morphological Tissue Context with an RNA In Situ Hybridization Assay

Published on: August 14, 2018

11.2K

Area of Science:

  • Oncology
  • Genetics
  • Molecular Biology

Background:

  • Advanced melanoma treatment relies on immune checkpoint inhibitors (ICIs) and targeted therapies.
  • Efficacy of current treatments is limited in acral and mucosal melanomas, common in non-White populations.
  • These melanoma subtypes often lack major driver mutations like BRAF, necessitating alternative therapeutic strategies.

Purpose of the Study:

  • To detect fusion genes in Japanese melanomas that lack common driver mutations (BRAF, RAS, NF1, KIT).
  • To evaluate the utility of RNA-based anchored multiplex polymerase chain reaction (AMP) for identifying fusion genes in clinical samples.

Main Methods:

  • Analysis of RNA from 14 Japanese melanoma tumors, mostly formalin-fixed paraffin-embedded.
  • Utilized a custom Archer FUSIONPlex panel for RNA-based fusion detection.
  • Developed and validated an anchored multiplex PCR (AMP) workflow, including quality control.

Main Results:

  • Successfully generated libraries from 80% of analyzed samples.
  • Identified two in-frame fusion genes: MAD1L1::BRAF and CIC::MEGF8 (17% of cases).
  • MAD1L1::BRAF retains the BRAF kinase domain, suggesting potential MEK inhibitor targeting. CIC::MEGF8 is a novel fusion potentially causing transcriptional dysregulation.

Conclusions:

  • RNA-based fusion detection is a valuable method for driver-negative melanomas.
  • Fusion genes represent promising actionable therapeutic targets for specific melanoma subtypes.
  • The described AMP workflow is applicable to clinical samples for fusion gene identification.